Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

3 Dec 2007 07:00

Gleeson(M J)Group PLC03 December 2007 Monday 3 December 2007 M J GLEESON GROUP PLC Board Changes Gleeson (GLE.L), the house-builder specialising in urban regeneration, ispleased to announce the appointment as a non-executive Director, with immediateeffect, of Colin Dearlove, formerly Group Finance Director of BarrattDevelopments plc, a FTSE 100 company. Colin Dearlove will replace Eric Stobart, who will retire from the Board on 31January 2008, at the conclusion of three three-year terms (the limit forcorporate governance considerations of independence). Colin Dearlove, BA, FCMA, aged 56, was at Barratt Developments, theNewcastle-based national house-builder, from 1981 to 2006, as Group ChiefAccountant from 1985 to 1992 and as Group Finance Director from 1992 to 2006. Save as disclosed above, Colin Dearlove has held no directorship in any otherpublicly quoted company at any time during the previous five years and thereare no details to be disclosed by Mr Dearlove under paragraph 9.6.13R of the Listing Rules. Welcoming Colin Dearlove to the Gleeson Board, Dermot Gleeson, Chairman, stated"My Board colleagues and I are delighted that someone of Colin's standing in thehouse-building industry is joining our Board. His considerable experience atBarratt Developments of implementing strategic change, and knowledge of the UKhousing market, particularly in the North of England, where much of Gleeson'sRegeneration business is located, are also major plusses." Thanking Eric Stobart for his contribution to the Gleeson Board, Dermot Gleesonstated "Eric Stobart, who has chaired the Audit Committee since 1999, has been atruly exceptional colleague. He has a huge depth of financial knowledge and hasproved to be an immensely wise and unflappable adviser. The Group owes him anenormous debt of gratitude" Notes for Editors: Following Colin Dearlove's appointment and Eric Stobart's retirement, theGleeson Board of Directors will comprise six members. Two are executive - PaulWallwork (Group Chief Executive) and Chris Holt (Group Finance Director) - andfour are non-executive - Dermot Gleeson (Chairman), Ross Ancell, Colin Dearloveand Terry Morgan. Enquiries: M J Gleeson Group plc 01252-360 300 Dermot Gleeson (Chairman)Paul Wallwork (Group Chief Executive) Bankside ConsultantsCharles Ponsonby 020-7367 8851 Photographs: Photographs of Colin Dearlove and Eric Stobart are available from Rose Oddy ofBankside Consultants at rose.oddy@bankside.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.